Zimmer Biomet Holdings, Inc. (ZBH)
99.50
+0.10
(+0.11%)
USD |
NYSE |
Sep 02, 16:00
99.50
0.00 (0.00%)
After-Hours: 20:00
Zimmer Biomet Holdings Research and Development Expense (TTM) : 442.90M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 442.90M |
| March 31, 2026 | 451.40M |
| December 31, 2025 | 458.60M |
| September 30, 2025 | 448.20M |
| June 30, 2025 | 443.90M |
| March 31, 2025 | 440.00M |
| December 31, 2024 | 437.30M |
| September 30, 2024 | 442.20M |
| June 30, 2024 | 447.50M |
| March 31, 2024 | 456.20M |
| December 31, 2023 | 458.70M |
| September 30, 2023 | 453.40M |
| June 30, 2023 | 438.20M |
| March 31, 2023 | 419.50M |
| December 31, 2022 | 406.00M |
| September 30, 2022 | 394.00M |
| June 30, 2022 | 386.10M |
| March 31, 2022 | 451.70M |
| December 31, 2021 | 435.80M |
| September 30, 2021 | 439.80M |
| June 30, 2021 | 431.90M |
| March 31, 2021 | 354.60M |
| December 31, 2020 | 372.00M |
| September 30, 2020 | 393.10M |
| June 30, 2020 | 421.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 446.00M |
| December 31, 2019 | 449.30M |
| September 30, 2019 | 429.40M |
| June 30, 2019 | 410.70M |
| March 31, 2019 | 397.70M |
| December 31, 2018 | 391.70M |
| September 30, 2018 | 385.50M |
| June 30, 2018 | 381.00M |
| March 31, 2018 | 374.50M |
| December 31, 2017 | 369.90M |
| September 30, 2017 | 370.60M |
| June 30, 2017 | 375.00M |
| March 31, 2017 | 371.00M |
| December 31, 2016 | 365.60M |
| September 30, 2016 | 355.80M |
| June 30, 2016 | 343.50M |
| March 31, 2016 | 306.30M |
| December 31, 2015 | 269.00M |
| September 30, 2015 | 229.70M |
| June 30, 2015 | 192.50M |
| March 31, 2015 | 189.20M |
| December 31, 2014 | 188.30M |
| September 30, 2014 | 188.10M |
| June 30, 2014 | 191.40M |
| March 31, 2014 | 198.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intuitive Surgical, Inc. | 1.414B |
| Stryker Corp. | 1.606B |
| Globus Medical, Inc. | 147.06M |
| Solventum Corp. | 715.00M |
| Boston Scientific Corp. | 2.153B |